Delta is moderately resistant to vaccines, particularly in people who have received just a single dose. However, a recently published study found that a single dose of either AstraZeneca's or Pfizer's vaccine reduced a person's risk of developing COVID-19 symptoms caused by the Delta variant by 33%, compared to 50% for the Alpha variant. A second dose of the AstraZeneca vaccine boosted protection against Delta to 60% (compared to 66% against Alpha). In comparison, two doses of Pfizer's vaccines were 88% effective (compared to 93% against Alpha). Based on this Govt of UK public health release, The difference in effectiveness between the vaccines after 2 doses may be explained by the fact that rollout of second doses of AstraZeneca was later than for the Pfizer-BioNTech vaccine. Studies of antibody profiles post-vaccination also show it takes longer to reach maximum effectiveness with the AstraZeneca vaccine. However, a recent release from the same source confirmed that the Pfizer-BioNTech vaccine is 96% effective against hospitalization after 2 doses. In comparison, the Oxford-AstraZeneca vaccine is 92% effective against hospitalization after 2 doses. Thus they have similar efficacy.